Related Experiment Video
Updated: Jun 18, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Three related cases of cutaneous anthrax in France: clinical and laboratory aspects
Gaël Cinquetti1, Frédéric Banal, Anne-Laure Dupuy
1From Service de Dermatologie (GC, ALD, PYG, AC, PG, YV), Service de Medecine Interne et Maladies Infectieuses et Tropicales (FB, BG), Service de Biologie (OO, CR, JMP), Hôpital d'Instruction des Armées Legouest, Metz; and Laboratoire de Bactériologie (CA), Centre Hospitalier et Universitaire de Nancy, Nancy, France.
Abstract:
Anthrax is an acute bacterial infection caused by Bacillus anthracis. The infection is cutaneous in about 95% of human cases and respiratory in about 5%. Approximately 2000 cases of cutaneous anthrax are reported annually worldwide. This disease became exceptional in Europe thanks to strict veterinarian monitoring. The last human cases of anthrax indicated in France were in 1997. We report 3 new related cases of naturally acquired cutaneous anthrax that occurred in France in 2008. The unique features of these cases include the atypical clinical presentation and the contribution of the rapid and specific diagnosis techniques by polymerase chain reaction.In cutaneous forms of anthrax, although the local course is not influenced by the treatment, antibiotic therapy is necessary to control any bacterial distribution. A case of exposure similar to that of a confirmed human case or an exposure identified by epidemiologic inquiry should usually result in chemoprophylaxis. Chemoprophylaxis for the close relations of a patient or for health workers is unnecessary since person-to-person transmission has not been reported.
Related Concept Videos
Inhalation Anthrax
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Endocarditis II: Clinical Features of Infective Endocarditis
